Skip Navigation

European Heart Journal 2002 23(1):88; doi:10.1053/euhj.2001.2633
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fernández, P.
Right arrow Articles by Sogorb, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernández, P.
Right arrow Articles by Sogorb, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letters to the Editor

The role of tissue plasminogen activator on the progression of the coronary disease

P. Fernándeza, P. Marcoa, F. Marína, V. Roldánb and F. Sogorba

a General Hospital of Alicante, Spain
b Hospital San Vicente, Spain

References

  1. Smith FB, Fowkes FGR, Rumley A, Lee AJ, Lowe GDO, Hau CM. Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study. Eur Heart J. 2000;21:1607–1613[Abstract/Free Full Text]
  2. Grant PJ. The Edinburgh Artery Study: is lytic activity bad for the heart? Eur Heart J. 2000;21:1566–1567[Free Full Text]
  3. Hamsten A. Hemostatic function and coronary artery disease. N Engl J Med. 1995;332:677–678[Free Full Text]
  4. Lijnen HR, Collen D. Impaired fibrinolysis and the risk for coronary heart disease. Circulation. 1996;94:2052–2054[Free Full Text]
  5. Koenig W. Haemostatic risk factors for cardiovascular diseases. Eur Heart J. 1998;19:39–43
  6. Cushman, M, Hemostatic risk factors for cardiovascular disease, 1999, 236, 42
  7. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. 1997;17:1859–1867[Free Full Text]
  8. Clowes AW, Clowes MM, Au YP, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990;67:61–67[Abstract/Free Full Text]
  9. Meigs JB, Mittleman MA, Nathan DM. Hyperinsulinemia, hyperglycemia and impaired hemostasis. The Framingham Offspring Study. JAMA. 2000;283:221–228[Abstract/Free Full Text]
  10. Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation. 1996;94:2057–2063[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fernández, P.
Right arrow Articles by Sogorb, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernández, P.
Right arrow Articles by Sogorb, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?